Data / Drug companies / Eywa Pharma Inc
Eywa Pharma Inc: 30 products in the FDA NDC directory, labeler code 71930
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Eywa Pharma Inc (labeler code 71930) lists 30 products in the FDA National Drug Code Directory, covering 12 finished drugs by generic name. By type: 30 prescription drugs. Its main marketing category is generic drugs (ANDA). The newest product started marketing on June 2, 2025.
The request: Watch Eywa Pharma Inc (FDA labeler code 71930): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 71930
- Products in commercial distribution
- 30
- Packages
- 48
- Finished drugs by generic name
- 12
- Prescription products
- 30
- Over the counter products
- 0
- Controlled substance products
- Schedule II 14, Schedule III 3
- Flagged as original packager
- 27 of 27 products that carry the flag
- Started marketing in the last 12 months
- 0
- Earliest marketing start
- June 1, 2018
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Generic drugs (ANDA) | 30 | 100% |
Products by type
| Type | Products | Share |
|---|---|---|
| Prescription drugs | 30 | 100% |
Drugs it lists
Finished drugs by generic name, with how many companies list each.
| Drug | Products | Companies listing it |
|---|---|---|
| Hydrocodone bitartrate and acetaminophen | 7 | 37 |
| Baclofen | 3 | 65 |
| Oxycodone and acetaminophen | 3 | 32 |
| Acetaminophen and codeine phosphate | 3 | 24 |
| Hydrocortisone | 3 | 171 |
| Acetazolamide | 2 | 37 |
| Methylphenidate hydrochloride | 2 | 39 |
| Oxycodone hydrochloride | 2 | 36 |
| Alosetron hydrochloride | 2 | 6 |
| Quinidine gluonate | 1 | 1 |
| Fludrocortisone acetate | 1 | 15 |
| Brompheniramine maleate, pseudoephedrine hydrochloride, | 1 | 1 |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet | 23 | 76.7% |
| Solution | 5 | 16.7% |
| Tablet, extended release | 1 | 3.3% |
| Syrup | 1 | 3.3% |
Pharmacologic classes
FDA established pharmacologic classes of its products.
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Fludrocortisone acetate | 71930-088 | Tablet | Generic drugs (ANDA) | June 2, 2025 |
| Hydrocortisone | 71930-080 | Tablet | Generic drugs (ANDA) | October 7, 2022 |
| Hydrocortisone | 71930-079 | Tablet | Generic drugs (ANDA) | October 7, 2022 |
| Hydrocortisone | 71930-078 | Tablet | Generic drugs (ANDA) | October 7, 2022 |
| Quinidine gluconate | 71930-016 | Tablet, extended release | Generic drugs (ANDA) | March 20, 2022 |
| Baclofen | 71930-066 | Tablet | Generic drugs (ANDA) | May 27, 2021 |
| Baclofen | 71930-007 | Tablet | Generic drugs (ANDA) | May 27, 2021 |
| Baclofen | 71930-006 | Tablet | Generic drugs (ANDA) | May 27, 2021 |
| Brompheniramine maleate, pseudoephedrine hydrochloride, | 71930-026 | Syrup | Generic drugs (ANDA) | June 26, 2020 |
| Acetazolamide | 71930-009 | Tablet | Generic drugs (ANDA) | January 30, 2020 |
| Acetazolamide | 71930-008 | Tablet | Generic drugs (ANDA) | January 30, 2020 |
| Acetaminophen and codeine phosphate | 71930-056 | Tablet | Generic drugs (ANDA) | August 2, 2019 |
| Acetaminophen and codeine phosphate | 71930-055 | Tablet | Generic drugs (ANDA) | August 2, 2019 |
| Acetaminophen and codeine phosphate | 71930-054 | Tablet | Generic drugs (ANDA) | August 2, 2019 |
| Hydrocodone bitartrate and acetaminophen | 71930-044 | Tablet | Generic drugs (ANDA) | June 17, 2019 |
| Hydrocodone bitartrate and acetaminophen | 71930-043 | Tablet | Generic drugs (ANDA) | June 17, 2019 |
| Hydrocodone bitartrate and acetaminophen | 71930-042 | Tablet | Generic drugs (ANDA) | June 17, 2019 |
| Oxycodone and acetaminophen | 71930-047 | Tablet | Generic drugs (ANDA) | June 1, 2019 |
| Oxycodone and acetaminophen | 71930-046 | Tablet | Generic drugs (ANDA) | June 1, 2019 |
| Oxycodone and acetaminophen | 71930-045 | Tablet | Generic drugs (ANDA) | June 1, 2019 |
| Hydrocodone Bitartrate and Acetaminophen | 71930-027 | Solution | Generic drugs (ANDA) | April 8, 2019 |
| Methylphenidate Hydrochloride | 71930-025 | Solution | Generic drugs (ANDA) | March 29, 2019 |
| Methylphenidate Hydrochloride | 71930-024 | Solution | Generic drugs (ANDA) | March 29, 2019 |
| Oxycodone Hydrochloride | 71930-022 | Solution | Generic drugs (ANDA) | March 1, 2019 |
| Alosetron Hydrochloride | 71930-011 | Tablet | Generic drugs (ANDA) | February 1, 2019 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.